lobbying_activities: 1813819

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1813819	0c037a8d-ae12-4b3d-a940-e15632243966	Q1	ARNALL GOLDEN GREGORY, LLP	400713137	PHARMA AND BIOPHARMA OUTSOURCING ASSOCIATION	2016	first_quarter	MED	FDA oversight issues of generic drugs; issues regarding generic drug user fees; 21st Century CURES Act; Innovation for Healthier Americans Act	HOUSE OF REPRESENTATIVES,SENATE			0	0	2016-04-19T10:40:36.057000-04:00